Prediction Case File
YouTubeTracking Live

Should You Buy Nike Stock Before the Huge Investor Update? | NKE STock Analysis

1 extracted signal · 0 resolved · 1 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFA22 Jun 2026, 11:45 UTC
Video preview for Should You Buy Nike Stock Before the Huge Investor Update? | NKE STock Analysis
Signals
1
Eligible signals in this source
Open
1
Still being tracked
Resolved
0
Evaluable outcomes
Successful
0
Canonical correct result
Failed
0
Canonical failed result
Resolved success
Not enough data
Open and excluded signals omitted
Source overview

AI-generated source summary

Nike's Q3 revenues were $11.3 billion, flat year-over-year on a reported basis and down 3% on a currency-neutral basis. Wholesale revenues were $6.5 billion (up 5% reported, up 1% currency-neutral), with Nike Direct revenues at $4.5 billion (down 4% reported, down 7% currency-neutral). Gross margin decreased 130 basis points to 40.2%, attributed to higher tariffs in North America. Diluted earnings per share were $0.35. The company's management notes meaningful actions taken to improve business health and quality, indicating a clear direction, but the work is not finished. The CEO stated that revenue growth has been in the mid-to-high single digits over longer-term periods, with some quarters experiencing double-digit declines due to strategy shifts. The company's current strategy involves focusing on direct-to-consumer sales and reducing reliance on wholesale partners. Inventories were $7.5 billion, down 1%, reflecting a decrease in units and product mix, partially offset by increased product costs. Cash and short-term investments were $8.1 billion. Selling and administrative expenses increased 2% to $4.0 billion, with demand creation expenses flat year-over-year at $1.1 billion. Concerns arise from the decline in Nike's Greater China sales (-7% reported, -10% currency-neutral) and the decrease in gross margin, particularly the EBIT margin which fell to 5.6% in the latest quarter from 7.3% a year ago. The stock is trading at $45.47, below its calculated intrinsic value of $36.21, suggesting potential undervaluation but with significant headwinds.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Parkev Tatevosian, CFA

Tracked signals
1097
Historical success
24.1%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.